1、 WORSWICK S, COTLIAR J. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options[J].Dermatol Ther, 2011,24(2):207-218. WORSWICK S, COTLIAR J. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options[J].Dermatol Ther, 2011,24(2):207-218.
2、 ZHU QY, MA L, LUO XQ, et al. Toxic epidermal necrolysis: performance of SCORTEN and the score-based comparison of the efficacy of corticosteroid therapy and intravenous immunoglobulin combined therapy in China[J].J Burn Care Res, 2012,33(6):e295-308. ZHU QY, MA L, LUO XQ, et al. Toxic epidermal necrolysis: performance of SCORTEN and the score-based comparison of the efficacy of corticosteroid therapy and intravenous immunoglobulin combined therapy in China[J].J Burn Care Res, 2012,33(6):e295-308.
3、 BARRON SJ, DEL VMT, ARONOFF SC. Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies[J].Int J Dermatol, 2015,54(1):108-115. BARRON SJ, DEL VMT, ARONOFF SC. Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies[J].Int J Dermatol, 2015,54(1):108-115.
4、 KIRCHHOF MG, MILISZEWSKI MA, SIKORA S, et al. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine[J].J Am Acad Dermatol, 2014,71(5):941-947. KIRCHHOF MG, MILISZEWSKI MA, SIKORA S, et al. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine[J].J Am Acad Dermatol, 2014,71(5):941-947.
5、 SEKULA P, LISS Y, DAVIDOVICI B, et al. Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study[J].J Burn Care Res, 2011,32(2):237-245. SEKULA P, LISS Y, DAVIDOVICI B, et al. Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study[J].J Burn Care Res, 2011,32(2):237-245.
6、 CHOONHAKARN C, LIMPAWATTANA P, CHAOWATTANAPANIT S. Clinical profiles and treatment outcomes of systemic corticosteroids for toxic epidermal necrolysis: A retrospective study[J].J Dermatol, 2015,42:1-6. CHOONHAKARN C, LIMPAWATTANA P, CHAOWATTANAPANIT S. Clinical profiles and treatment outcomes of systemic corticosteroids for toxic epidermal necrolysis: A retrospective study[J].J Dermatol, 2015,42:1-6.
7、 BASTUJI-GARIN S, FOUCHARD N, BERTOCCHI M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis[J].J Invest Dermatol, 2000,115(2):149-153. BASTUJI-GARIN S, FOUCHARD N, BERTOCCHI M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis[J].J Invest Dermatol, 2000,115(2):149-153.
8、DODIUK-GAD RP, CHUNG WH, VALEYRIE-ALLANORE L, et al. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update[J].Am J Clin Dermatol, 2015,16(16):475-493.DODIUK-GAD RP, CHUNG WH, VALEYRIE-ALLANORE L, et al. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update[J].Am J Clin Dermatol, 2015,16(16):475-493.
9、 SCHNECK J, FAGOT JP, SEKULA P, et al. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study[J].J Am Acad Dermatol, 2008,58(1):33-40. SCHNECK J, FAGOT JP, SEKULA P, et al. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study[J].J Am Acad Dermatol, 2008,58(1):33-40.
10、 SCHWARTZ RA, McDONOUGH PH, LEE BW. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment[J].J Am Acad Dermatol, 2013,69(2):187.e1-16. SCHWARTZ RA, McDONOUGH PH, LEE BW. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment[J].J Am Acad Dermatol, 2013,69(2):187.e1-16.
